INS and endometrial cancer: In order to examine gene expression variation in endometrial cancer cells following treatment with insulin glargine, detemir, regular insulin, or IGF1 (in comparison to untreated control cells), the Affymetrix® Human Gene 2.1 ST Array was employed.